drugset / Trial / NCT01737879
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Patients Receiving Hemodialysis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate whether hemodialysis patients on peginesatide can be converted to epoetin alfa by using a predefined conversion table while achieving a stable hemoglobin.
Timeline
- Start
- 2012-10
- Primary completion
- 2013-03
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | — | Intravenous |
| Subject | peginesatide | Peptide | — | Intravenous |